z-logo
open-access-imgOpen Access
Gene Expression Profiling Supports the Neural Crest Origin of Adult Rodent Carotid Body Stem Cells and Identifies CD10 as a Marker for Mesectoderm‐Committed Progenitors
Author(s) -
NavarroGuerrero Elena,
PlateroLuengo Aida,
LinaresClemente Pedro,
Cases Ildefonso,
LópezBarneo José,
Pardal Ricardo
Publication year - 2016
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1002/stem.2331
Subject(s) - biology , progenitor cell , microbiology and biotechnology , stem cell , neural stem cell , neurosphere , neural crest , population , multipotent stem cell , adult stem cell , cellular differentiation , immunology , genetics , gene , embryo , demography , sociology
A bstract Neural stem cells (NSCs) are promising tools for understanding nervous system plasticity and repair, but their use is hampered by the lack of markers suitable for their prospective isolation and characterization. The carotid body (CB) contains a population of peripheral NSCs, which support organ growth during acclimatization to hypoxia. We have set up CB neurosphere (NS) cultures enriched in differentiated neuronal (glomus) cells versus undifferentiated progenitors to investigate molecular hallmarks of cell classes within the CB stem cell (CBSC) niche. Microarray gene expression analysis in NS is compatible with CBSCs being neural crest derived‐multipotent progenitor cells able to sustain CB growth upon exposure to hypoxia. Moreover, we have identified CD10 as a marker suitable for isolation of a population of CB mesectoderm‐committed progenitor cells. CD10 + cells are resting in normoxia, and during hypoxia they are activated to proliferate and to eventually complete maturation into mesectodermal cells, thus participating in the angiogenesis necessary for CB growth. Our results shed light into the molecular and cellular mechanisms involved in CBSC fate choice, favoring a potential use of these cells for cell therapy. S tem C ells 2016;34:1637–1650

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here